iGaming Compliance Representative PGCB

The iGaming Compliance Representative role participates in key processes to ensure integrity in the iGaming industry as part of the Pennsylvania Gaming Control Board (PGCB), Bureau of Gaming Operations, iGaming Unit. This position evaluates new technology and upholds high standards to keep online and interactive gaming applications and platforms operating legally and safely.

Responsibilities

• iGaming Analysis: Monitor, review, verify, and report on iGaming programs, applications, software, and system architecture to ensure compliance with laws, rules, regulations, and internal controls.
• Change Evaluation: Assess updates to iGaming applications and related platforms to validate and test approved operations and functionality.
• Patron Assistance: Receive and investigate patron complaints; conduct and aid patron self-exclusions.
• Incident Reporting: Analyze facts to draw logical conclusions and prepare investigative reports to communicate findings.
• Enforcement Support: Coordinate corrective actions with interactive gaming industry managers and refer or recommend administrative, regulatory, or criminal actions to other bureaus or offices within PGCB.

Schedule

• Full-time employment, 37.5 hours per week.
• Work hours are 8:30 AM to 5:00 PM, Monday - Friday, with a 30-minute lunch.
• Telework: Opportunity to work from home (telework) part-time with a securely configured high-speed internet connection from an approved location inside Pennsylvania. If unable to telework, reporting to the headquarters office in Harrisburg is required. Telework eligibility is subject to change.

Qualifications

• Minimum Experience and Training Requirements:
  • A Bachelor’s degree; or
  • Four years of security or surveillance experience of a technical level; or
  • An equivalent combination of experience and training.
• Must be able to perform essential job functions.
• Employment is contingent upon completion of a Personal History Questionnaire with a thorough background investigation, including drug screening, and subsequent review and approval by the Board.